Meiji Yasuda Asset Management CO Ltd. Abb Vie Inc. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.42 Billion
- Q1 2025
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 183,352 shares of ABBV stock, worth $34.1 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
183,352
Previous 215,333
14.85%
Holding current value
$34.1 Million
Previous $38.3 Million
0.39%
% of portfolio
1.59%
Previous 1.5%
Shares
31 transactions
Others Institutions Holding ABBV
# of Institutions
4,264Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.4 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.2 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.66 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $329B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...